B.P. Marsh & Partners
BPM · AIM · Financial Services · mcap £232m · 655.0p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 07 Oct 26 | Holding | Holding(s) in Company | |
| 06 Oct 26 | New Investment: Dauntless U/W Limited
B.P. Marsh acquires 30% stake in new marine underwriting agency Dauntless and provides £2.0m loan facility. |
+0.6% | |
| 29 Sep 26 | Purchase of Own Shares and Total Voting Rights
Purchase of Own Shares and Total Voting Rights |
+0.0% | |
| 25 Sep 26 | Purchase of Own Shares and Total Voting Rights
Purchase of Own Shares and Total Voting Rights |
+0.0% | |
| 23 Sep 26 | Director dealing | PDMR - Correction
Correction to director share purchase notification from April 2025 with additional shares purchased. |
−0.6% |
| 23 Sep 26 | Purchase of Own Shares and Total Voting Rights
Purchase of Own Shares and Total Voting Rights |
−0.6% | |
| 23 Sep 26 | Notice of HY Results and Investor Presentation
Notice of Half Year Results and Investor Presentation |
−0.6% | |
| 22 Sep 26 | Trading update | Trading Update
Three new investments completed, portfolio growing, 45 business enquiries received, funds of £37.4m. |
−1.2% |
| 21 Sep 26 | Purchase of Own Shares and Total Voting Rights
Purchase of Own Shares and Total Voting Rights |
+0.0% | |
| 17 Sep 26 | Purchase of Own Shares and Total Voting Rights
Purchase of Own Shares and Total Voting Rights |
+0.0% | |
| 16 Sep 26 | Purchase of Own Shares and Total Voting Rights
Purchase of Own Shares and Total Voting Rights |
−0.2% | |
| 15 Sep 26 | Holding | Holding(s) in Company | |
| 15 Sep 26 | Director dealing | Transaction in Own Shares, Director Dealings & TVR | |
| 15 Sep 26 | Correction to RNS 6991U Exercise Of Options & TVR
The following amendments have been made to the 'Exercise Of Options and Total Voting Rights' announcement released on 14 September 2026 at 16:32 under RNS No 6991U. |
+0.2% | |
| 14 Sep 26 | Routine | Exercise Of Options and Total Voting Rights | |
| 11 Sep 26 | Routine | Transaction in Own Shares | |
| 10 Sep 26 | Routine | Transaction in Own Shares | |
| 09 Sep 26 | Routine | Transaction in Own Shares | |
| 14 Aug 26 | Purchase of Own Shares and Total Voting Rights
Purchase of Own Shares and Total Voting Rights |
+0.0% | |
| 13 Aug 26 | Purchase of Own Shares and Total Voting Rights
Purchase of Own Shares and Total Voting Rights |
+0.0% | |
| 12 Aug 26 | Purchase of Own Shares and Total Voting Rights
Purchase of Own Shares and Total Voting Rights |
−2.0% | |
| 11 Aug 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 10 Aug 26 | Purchase of Own Shares and Total Voting Rights
Purchase of Own Shares and Total Voting Rights |
+0.0% | |
| 03 Aug 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 31 Jul 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 30 Jul 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 29 Jul 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 28 Jul 26 | Routine | Transaction in Own Shares | |
| 27 Jul 26 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 24 Jul 26 | Routine | Transaction in Own Shares | |
| 23 Jul 26 | Routine | Transaction in Own Shares | |
| 21 Jul 26 | Routine | Transaction in Own Shares | |
| 15 Jul 26 | New Share Buyback Programme
B.P. Marsh launches new share buyback programme for up to £2 million, replacing previous programme. |
+1.2% | |
| 13 Jul 26 | Director dealing | Director/PDMR Shareholding | |
| 08 Jul 26 | Routine | Result of AGM | |
| 08 Jul 26 | Director dealing | Director/PDMR Shareholding | |
| 08 Jul 26 | Director dealing | Director/PDMR Shareholding | |
| 25 Jun 26 | Investment in Autonomy Investment Partners
B.P. Marsh invests $5.1m in Autonomy Investment Partners, a new vehicle to invest in US insurance distribution businesses. |
+0.0% | |
| 23 Jun 26 | Receipt of Deferred Consideration
B.P. Marsh received £5.1m second tranche of deferred consideration from sale of Aspira subsidiary. |
+0.0% | |
| 16 Jun 26 | Final Dividend Declaration
Final dividend of 6.98p per share proposed, subject to shareholder approval at AGM. |
+0.0% | |
| 16 Jun 26 | Routine | Notice of AGM | |
| 29 May 26 | Director dealing | Director/PDMR Shareholding | |
| 27 May 26 | Results | Final Results
NAV grew 10.3% to £360.2m; paid £8.0m dividends; completed two disposals and eight new investments. |
+2.2% |
| 27 May 26 | Board change | Directorate Change
Founder Brian Marsh steps down after 35 years; Rebecca Shelley appointed Independent Non-Executive Chair. |
+2.2% |
| 13 May 26 | Routine | Transaction in Own Shares | |
| 06 May 26 | Routine | Notice of Results and Investor Presentation | |
| 24 Apr 26 | Routine | Transaction in Own Shares | |
| 20 Apr 26 | Director dealing | SIP Awards, PDMR Dealings, Treasury Shares, TVR
16,512 shares awarded to 12 employees under Share Incentive Plan at 653p per share. |
−0.6% |
| 16 Apr 26 | Deferred Consideration Receipt & Special Dividend
Received final £9.5m deferred consideration from Paladin sale; intends to pay £2.0m special dividend in FY28. |
+0.9% | |
| 14 Apr 26 | Routine | Transaction in Own Shares | |
| 08 Apr 26 | Routine | Transaction in Own Shares | |
| 02 Apr 26 | Follow-on equity purchase in Pantheon
B.P. Marsh increases stake in Pantheon Specialty Group to 41% with additional 2% equity purchase. |
+0.0% | |
| 31 Mar 26 | Routine | Transaction in Own Shares | |
| 30 Mar 26 | Director dealing | Director/PDMR Shareholding | |
| 26 Mar 26 | New Share Buyback Programme
B.P. Marsh launches new £2 million share buyback programme managed by Singer Capital Markets. |
+0.0% | |
| 18 Mar 26 | New Investment: Nine Edge Wealth Limited
B.P. Marsh invests in new IFA platform Nine Edge Wealth with £5m loan facility and 30% equity stake. |
+0.5% | |
| 18 Mar 26 | New Investment: Ventura Risk Partners Holdings
B.P. Marsh invests in Ventura Risk Partners, acquiring 25% equity and providing £2.0m loan facility. |
+0.5% | |
| 17 Mar 26 | Sale of Interest in Amiga to Sodalis
B.P. Marsh sold its 39.24% stake in Amiga to portfolio company Sodalis for £706,250 cash and £1.825m loan repayment. |
−2.0% | |
| 11 Mar 26 | Update on Sodalis Capital Limited
Portfolio company Sodalis Capital launched Brecon Specialty, a London-based wholesale insurance broker focused on cyber and technology risks. |
+0.0% | |
| 24 Feb 26 | Trading update | Trading Update
Eight new investments completed, two disposals generating £30.7m, dividends of £13.0m planned for FY2027. |
+3.7% |
| 06 Feb 26 | Purchase of Own Shares and Total Voting Rights
Purchase of Own Shares and Total Voting Rights |
−0.3% | |
| 05 Feb 26 | Routine | Transaction in Own Shares | |
| 21 Jan 26 | Interim Dividend Declaration
Interim dividend of 6.98p per share declared, payable February 2026, with special dividend of 22.33p in March. |
+0.0% | |
| 18 Dec 25 | Routine | Transaction in Own Shares and Total Voting Rights | |
| 15 Dec 25 | Special Dividend Declaration
Special dividend of 22.33p per share declared following £27.6m proceeds from Stewart Specialty Risk disposal. |
+1.7% | |
| 11 Dec 25 | Appointment of Nominated Adviser and Joint Brokers
Marsh & Partners PLC (AIM: BPM), the specialist venture capital investor in early-stage financial services businesses, announces the appointment of Singer Capital Markets as the Company's Nominated Adviser and Joint Brok |
−1.5% | |
| 02 Dec 25 | Change in Executive Directorship Roles
Brian Marsh steps down as Executive Chairman to Non-Executive; Dan Topping becomes CEO; Alice Foulk becomes COO. |
−0.8% | |
| 27 Nov 25 | Routine | Transaction in Own Shares | |
| 27 Nov 25 | New Investment: Sodalis Capital Limited
B.P. Marsh invests £5.3m for 26.67% stake in new insurance intermediary group Sodalis alongside Alliant. |
+0.0% | |
| 25 Nov 25 | Routine | Transaction in Own Shares | |
| 24 Nov 25 | Routine | Transaction in Own Shares | |
| 24 Nov 25 | Routine | Transaction in Own Shares | |
| 21 Nov 25 | Routine | Transaction in Own Shares | |
| 20 Nov 25 | Routine | Transaction in Own Shares | |
| 19 Nov 25 | Routine | Transaction in Own Shares | |
| 17 Nov 25 | Routine | Transaction in Own Shares | |
| 13 Nov 25 | B.P. Marsh to present at MelloLondon
Chief Investment Officer to present at MelloLondon investor event on 18 November 2025. |
+0.1% | |
| 11 Nov 25 | Routine | Transaction in Own Shares | |
| 07 Nov 25 | Routine | Transaction in Own Shares | |
| 06 Nov 25 | Routine | Transaction in Own Shares | |
| 05 Nov 25 | Routine | Transaction in Own Shares | |
| 04 Nov 25 | Routine | Transaction in Own Shares | |
| 30 Oct 25 | Routine | Transaction in Own Shares | |
| 28 Oct 25 | Routine | Transaction in Own Shares | |
| 28 Oct 25 | Sale of Stewart Specialty Risk Underwriting
B.P. Marsh sold 28.2% stake in Canadian underwriter SSRU to Ryan Specialty for CAD $51.9m cash. |
+2.1% | |
| 27 Oct 25 | Routine | Transaction in Own Shares | |
| 21 Oct 25 | Results | Half-year Results
NAV increased to £349.5m, up 7.1% in H1 2025; total shareholder return of 9.5% including dividends. |
+0.9% |
| 07 Oct 25 | Notice of HY Results and Investor Presentation
Notice of Half Year Results and Investor Presentation |
−1.0% |
Company filings. Not investment advice.